Bio Pappel SAB Cash Flow - Quarterly (OTCMKTS:CDURQ)

Add to My Stocks
$1.5 $0.05 (3.23%) CDURQ stock closing price Dec 07, 2017 (Closing)

The Bio Pappel SAB cash flow statement is one of the important reports considered by investors doing a fundamental analysis of the company. The profit-loss statement shows Bio Pappel SAB profits, the balance sheet shows Bio Pappel SAB debt, and the cash flow statement reflects the liquidity and solvency of a firm. This statement reflects the company's ability to generate cash flows. Bio Pappel SAB stock analysis shows negative net income cash flow of $-2.38M till 2016 Q3. This statement is important because profits alone cannot pay employees, or bills. Cash is required. The cash from operating activities for Bio Pappel SAB is $ 2016 Q3, which saw an increase from previous quarter.

View and download details of Bio Pappel SAB cash flows for latest & last 40 quarters
show more
Fiscal year is Jan - Dec2016 Q32016 Q22015 Q4
Net Income Cash Flow
-2.38M-4.44M15.02M
Depreciation Depletion Amortization Cash-Flow38.43M26.39M44.81M
Net Increase (Decrease) in Assets Liabilities-53.1M-49.64M36.31M
Cash From (used in) Discontinued Operations---
Other Adjustments Net128.39M93.53M106.71M
Net Cash from (used by) Operating Activities
111.34M65.82M202.85M
Increase (Decrease) in Prop Plant And Equipment-24.37M-18.53M-19.08M
Acquisition Disposition of Subsidiaires---121.94M
Increase (Decrease) in Investments-1.56M-0.16M-
Other Cash Inflow (Outflow) from Investment Activities1.54M1.28M22.53M
Net Cash from (used by) Investment Activities
-24.4M-17.41M-118.49M
Issuance (Purchase) of Equity Shares---
Issuance (Repayment) of Debt Securities-86.82M-50.17M42.96M
Increase (Decrease) in Bank & Other Borrowings---
Payment of Dividends & Other Cash Distributions---
Other Cash from (used by) Financing Activities-29.6M-27.13M-44.94M
Net Cash from (used by) Financing Activities
-116.43M-77.31M-1.98M
Effect of Exchange Rate Changes on Cash19.38M13.16M13.12M
Net Change in Cash & Cash Equivalents
-10.09M-15.73M95.5M
Cash & Equivalents at Beginning of Year52.56M77.44M49.19M
Cash & Equivalents at Year End141.78M141.55M179.76M
All figures in USD. M: Millions of USD, B: Billions of USD.

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The Bio Pappel SAB stock price history and Bio Pappel SAB stock comparison chart inevitably reflect its cash flow situation.

  • Bio Pappel SAB has cash of $141.78M on hand. A healthy amount of cash on hand is necessary for any company. Cash has an opportunity cost associated with it, and too much cash in bank may mean that the firm has no or limited growth plans. Hence its important to track the Net Change in Cash and Cash Equivalents along with the Bio Pappel SAB stock price.
  • Bio Pappel SAB increased its cash from operating activities to $111.34M till 2016 Q3. Operating activities include production of goods or creating a product or providing a service, and collecting payment for the same from customers. The cash generated from these activities is refered to as cash flow from operating activities.
  • Growth companies, typically most tech companies; spend heavily on investing activities and this figure stood at $-24.4M for CDURQ stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
  • Cash flow from financing activities shows the flow of cash between Bio Pappel SAB and its owners and creditors and was $-116.43M till 2016 Q3. Financing activities allow a company to raise capital, and repay bondholders.

Key Financial Ratios For Bio Pappel SAB Cash Flow

Quarterly Cash Flow Statements For Bio Pappel SAB de CV (ADR) Peers

Clearwater Paper cash flow, Hadera Paper cash flow, MONDI PLC UNS cash flow, Sugarmade cash flow